Ticker

No recent analyst price targets found for ISPR.

Latest News for ISPR

IKE Tech Engages FDA on Next-Generation Compliance Infrastructure for ENDS

Companies outline public health case for point-of-use enforcement technologies and call for regulatory framework recognizing compliance software as a tobacco product LOS ANGELES, April 9, 2026 /PRNewswire/ -- IKE Tech LLC ("IKE Tech"), an AI-powered compliance infrastructure company and joint venture among Ispire Technology Inc. (NASDAQ: ISPR), Berify, and Chemular Inc., participated in a formal listening session…

PRNewsWire • Apr 9, 2026
Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value

FDA establishes first-ever framework for flavored ENDS, recognizing device level age verification as a regulatory requirement FDA guidance unlocks an estimated $50 billion total addressable market, allowing companies to lawfully transition the 70% illicit flavored vape market into a compliant ecosystem Ispire's 40%-owned IKE Tech joint venture is positioned to generate $5 million to $20 million in annual recurring…

PRNewsWire • Mar 16, 2026
Ispire Technology Inc. to Participate in the 38th Annual ROTH Conference

LOS ANGELES, March 11, 2026 /PRNewswire/ -- Ispire Technology Inc. ( NASDAQ: ISPR ) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced that Ispire's management team will participate in the 38th Annual ROTH Conference taking place in Dana Point, California from March 22-24, 2026. 38th Annual ROTH Conference Date: March 22-24, 2026 Location: Dana…

PRNewsWire • Mar 11, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for ISPR.

No House trades found for ISPR.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top